Philippe Motté has more than 15 years expertise in regulatory affairs and market access in Europe. He is a pharmacist, and holds a PhD in biochemistry and a MBA. His career in the industry has developed in regulatory affairs and market access which gives him a broad expertise and large perspective on making innovative products available to patients in Europe. In regulatory affairs, his expertise was gained at SmithKline Beecham (now GSK) where he registered the first hepatitis A vaccine, and then various vaccines through the European procedures. In market access, he managed access of major innovative drugs for Roche in France, like peginterferon, trastuzumab, rituximab and many others. His experience was even deepened at Ipsen where he was successively managing the regulatory and market access team in France, and then became Senior Director for Europe Regulatory Affairs and then Vice President, Global Regulatory Affairs. In 2013, Philippe joined AbbVie as Head of Western Europe Regulatory Affairs, and he is now Vice President Regulatory Affairs International, covering all geographies except North America. In all those positions, Philippe has gained expertise in many regulatory procedures, in Europe and other markets, and in interacting with health authorities and industry associations. Philippe is also Associate Professor at the University of Paris where he teaches Regulatory Affairs in the School of Pharmacy.